Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients

[1]  J A Helpern,et al.  In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia , 1989, Neurology.

[2]  R. Martins,et al.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. , 1989, The New England journal of medicine.

[3]  R. Wurtman,et al.  Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum , 1989, Brain Research.

[4]  S. Kish,et al.  Down's Syndrome Individuals Begin Life with Normal Levels of Brain Cholinergic Markers , 1989, Journal of neurochemistry.

[5]  K. Ogomori,et al.  Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. , 1989, The American journal of pathology.

[6]  M. Wayner,et al.  Kinetic properties of the [Ca2+ + Mg2+]-ATPase in Alzheimer and normal fibroblasts at low free calcium , 1988, Brain Research Bulletin.

[7]  J. Pettegrew,et al.  Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease. , 1988, Archives of neurology.

[8]  J. Coyle,et al.  Down syndrome, Alzheimer's disease and the trisomy 16 mouse , 1988, Trends in Neurosciences.

[9]  J. Pettegrew,et al.  31P Nuclear Magnetic Resonance Study of the Brain in Alzheimer's Disease , 1988, Journal of neuropathology and experimental neurology.

[10]  R. Ferrell,et al.  Monozygotic twins concordant for probable Alzheimer disease and increased platelet membrane fluidity. , 1988, American journal of medical genetics.

[11]  B. Cohen,et al.  Family study of platelet membrane fluidity in Alzheimer's disease. , 1987, Science.

[12]  J. Blusztajn,et al.  Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Zubenko.  Proliferation of Internal Membranes in Platelets from Patients with Alzheimer's Disease , 1987, Journal of neuropathology and experimental neurology.

[14]  N. Minshew,et al.  31P Nuclear Magnetic Resonance Studies of Phosphoglyceride Metabolism in Developing and Degenerating Brain: Preliminary Observations , 1987, Journal of neuropathology and experimental neurology.

[15]  B. Cohen,et al.  Abnormal platelet membrane composition in Alzheimer's-type dementia. , 1987, Life sciences.

[16]  V. Yong,et al.  Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease , 1987, Annals of neurology.

[17]  J. Hawthorne,et al.  Reduced Phosphoinositide Concentrations in Anterior Temporal Cortex of Alzheimer‐Diseased Brains , 1987, Journal of neurochemistry.

[18]  F. Buonanno,et al.  In Vitro31P NMR Spectroscopy Detects Altered Phospholipid Metabolism in Alzheimer's Disease , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[19]  G. Zubenko.  Hippocampal membrane alteration in Alzheimer's disease , 1986, Brain Research.

[20]  J. Goldman,et al.  Cytosolic free calcium and cell spreading decrease in fibroblasts from aged and Alzheimer donors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Ebstein,et al.  Age related decline in aluminum-activated human platelet adenylate cyclase: post-receptor changes in cyclic AMP second messenger signal amplification in normal aging and dementia of the Alzheimer type. , 1986, Life sciences.

[22]  J. Kanfer,et al.  Reduced phosphorylcholine hydrolysis by homogenates of temporal regions of Alzheimer's brain. , 1986, Biochemical and biophysical research communications.

[23]  J. Kanfer,et al.  Reduced phospholipase D activity in brain tissue samples from Alzheimer's disease patients , 1986, Annals of neurology.

[24]  J. G. Goekoop,et al.  Lymphocyte concanavalin A capping: a similarity between Down's syndrome and early onset primary degenerative dementia. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[25]  J. Goldman,et al.  Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Jenden,et al.  Abnormal erythrocyte choline and influx in Alzheimer's disease. , 1986, Life sciences.

[27]  R. Wurtman,et al.  “Autocannibalism” of choline-containing membrane phospholipids in the pathogenesis of Alzheimer's disease—A hypothesis , 1985, Neurochemistry International.

[28]  R. Wurtman,et al.  High-performance liquid chromatography of water-soluble choline metabolites. , 1985, Analytical biochemistry.

[29]  Z. Khachaturian.  Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[30]  M. Bárány,et al.  INCREASED GLYCEROL-3-PHOSPHORYLCHOUNE IN POST-MORTEM ALZHEIMER'S BRAIN , 1985, The Lancet.

[31]  Suzanne Corkin,et al.  CELL MEMBRANE ABNORMALITY IN ALZHEIMER'S DISEASE , 1984, The Lancet.

[32]  P. Mcgeer,et al.  Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain , 1984, Neurology.

[33]  J. Simpson,et al.  Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and down's syndrome , 1983, Brain Research.

[34]  R. Wurtman,et al.  Choline and cholinergic neurons. , 1983, Science.

[35]  T. Perry,et al.  Postmortem Changes of Amino Compounds in Human and Rat Brain , 1981, Journal of neurochemistry.

[36]  E K Perry,et al.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.

[37]  D M Bowen,et al.  Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. , 1976, Brain : a journal of neurology.

[38]  P. Quinn,et al.  A novel pathway for phosphatidylcholine catabolism in rat brain homogenates. , 1975, Biochimica et biophysica acta.

[39]  R. Mccaman,et al.  THE DETERMINATION OF PICOMOLE AMOUNTS OF ACETYLCHOLINE IN MAMMALIAN BRAIN , 1973, Journal of neurochemistry.

[40]  R. Thompson,et al.  Glycerylphosphorylcholine diesterase activity of nervous tissue. , 1957, The Biochemical journal.

[41]  K. Beyreuther,et al.  Molecular biology of Alzheimer's disease. , 1989, Annual review of biochemistry.

[42]  D. Selkoe,et al.  Biochemistry of altered brain proteins in Alzheimer's disease. , 1989, Annual review of neuroscience.

[43]  Nicholas J Hicks,et al.  PLATELET MEMBRANE PROPERTIES IN ALZHEIMER AND MULTI-INFARCT DEMENTIAS , 1987, Alzheimer disease and associated disorders.